Medicare rules, CMS guidance, reimbursement, and benefit changes affecting patients and providers.
CMS is asking states to break out more Medicaid and CHIP quality results by race and ethnicity, sex, and geography in 2026. That could make gaps in child, pregnancy, and behavioral health care easier to see, but better reporting alone will not fix unequal care.
CMS now requires hospitals to report clearer dollar-based pricing fields in their machine-readable files for 2026. That could make gathered pricing data easier to analyze, but it still does not give most patients an exact out-of-pocket quote.
Medicare covers some diabetes-related foot care in 2026, but not unlimited routine foot care for everyone. Here’s who qualifies for Part B foot exams and treatment every 6 months, what therapeutic shoes may be covered, what you may pay, and which symptoms should be checked sooner.
As of March 27, 2026, the CDC still clearly recommends 2 doses of the 2025–2026 COVID-19 vaccine for adults 65 and older. Here is how the timing works, why age still matters, what Medicare covers, and what remains uncertain.
A 2026 Medicare policy update gives eligible beneficiaries more ways to join the Medicare Diabetes Prevention Program, including live online and on-demand sessions through December 31, 2029. Here’s who qualifies, what the program includes, what Medicare pays, and why the access change matters for older adults with prediabetes.
Medicare has extended many telehealth flexibilities through 2026. Here’s what that means for receiving care at home, what’s covered, what you pay, and what could change next.
A new March 2026 report from MedPAC examines how Medicare payment policy is affecting rural hospital finances and the rise of Rural Emergency Hospitals. Here’s what it means for emergency access, maternity care, travel distances, and insurance coverage in rural communities.
CDC’s 2025–2026 recommendations for influenza, COVID-19, and RSV vaccination clarify who should be vaccinated, when doses should be given, and how coverage works under Medicare and private insurance. Here’s what patients and physicians need to know this season.
New FDA-approved obesity medications have changed treatment options—but Medicare’s long-standing drug coverage rules still shape who can access them. Here’s what adults and families should understand in 2026 about eligibility, costs, and policy limits.
FDA-approved anti-amyloid drugs such as lecanemab are now in real-world use for early Alzheimer’s disease. Here’s who qualifies, what the main clinical trial showed, what ARIA risks mean, and how Medicare coverage works in the United States.
FDA traditional approval of lecanemab for early Alzheimer’s disease offers modest slowing of decline for some patients—but requires careful screening, MRI monitoring, and meeting Medicare coverage rules. Here’s what families should understand in 2026.
CMS has finalized the 2026 Medicare Physician Fee Schedule, updating how doctors are paid, refining telehealth rules, and adjusting quality programs. Here’s what those changes could mean for appointment access, costs, and care coordination.
In 2026, Medicare beneficiaries are seeing the first real-world effects of negotiated drug prices and a new $2,000 annual out-of-pocket cap under Part D. Here’s what changed, which drugs are affected, and what to check with your plan.
The CDC’s 2026 immunization schedules reflect updated ACIP recommendations for children, teens, and adults. Here’s what changed, who may be newly eligible, and how those recommendations affect insurance coverage under the ACA, Medicare Part D, Medicaid, and the Vaccines for Children program.
Severe low blood sugar remains a preventable but dangerous complication of diabetes. Updated 2026 guidelines from the American Diabetes Association emphasize broader continuous glucose monitoring, safer medication choices, and ready-to-use glucagon — with important insurance implications for older adults.
CMS has finalized its 2026 payment rule for hospital outpatient departments and ambulatory surgery centers. Here’s what the changes mean for Medicare patients, hospital finances, and where you receive care.
OTC hearing aids are now widely available for adults with mild to moderate hearing loss. Here’s what the FDA requires, how they differ from prescription devices, what traditional Medicare does and does not cover, and when a medical exam is still essential.
Hospitals and insurers now publish more pricing data than ever, including negotiated rates and cash prices. Here’s what those files actually show, how CMS is enforcing compliance in 2026, and what they mean for your out-of-pocket costs.
New federal rules are rolling out in 2026–2027 to shorten prior authorization timelines, require clearer denial explanations, and move more requests online for certain Medicare Advantage, Medicaid, CHIP, and Marketplace plans. Here’s what’s changing — and what it means for patients.
CMS has finalized its 2026 Medicare Advantage payment update, outlining how plan payments, risk adjustment, and quality bonuses will change next year. Here’s what that could mean for premiums, extra benefits, and provider networks.
New CMS rules are changing how prior authorization works for many Medicare Advantage, Medicaid managed care, CHIP, and ACA Marketplace plans. Here’s what’s different in 2026, what hasn’t changed, and what to do if your care is delayed or denied.
In 2026, the first negotiated drug prices under Medicare’s new program take effect. Here’s what that means for seniors, how the Maximum Fair Price works, and how the $2,000 Part D cap fits in.
End of content
End of content
